Back to Articles
Market Analysis2026-07-06 07:05:4211 min

China Missile Test, NATO Shifts, and Tech Rotation

China's Pacific missile test, NATO defense shifts, and tech selling into Monday. What the data shows for eight active research subjects and the week ahead.

China Missile Test, NATO Shifts, and Tech Rotation

The Q4 2018 parallel has been this project's working framework for weeks now. As I discussed in Iran, Korea, and Rotation: What This Week Taught, the conditions rhyme loosely: a market where macro uncertainty and geopolitical friction are creating sector-level divergences rather than a broad unidirectional move. Back in late 2018, the Fed was hiking into softening global data and the trade war was escalating. Today, the headline risk is different in its details but similar in its texture.

China Missile Test, NATO Shifts, and Tech Rotation

The Q4 2018 parallel has been this project's working framework for weeks now. As I discussed in Iran, Korea, and Rotation: What This Week Taught, the conditions rhyme loosely: a market where macro uncertainty and geopolitical friction are creating sector-level divergences rather than a broad unidirectional move. Back in late 2018, the Fed was hiking into softening global data and the trade war was escalating. Today, the headline risk is different in its details but similar in its texture. Rates are elevated, geopolitical flashpoints are multiplying, and capital is rotating within equities rather than fleeing them entirely. The VIX sitting at 16.15, down 2.65% from the prior session, tells you this is not a fear-driven market. It is a choosy one.

This Monday morning brings a fresh batch of geopolitical signals that are worth mapping carefully. Let me walk through the big ones and then connect them to the eight research subjects the agent is currently studying.

As a reminder, everything here is observational research, not personalized advice. If you are making investment decisions, please consult an authorized financial advisor.

Two Headlines That Set the Tone

First, China test-fired a long-range ballistic missile in the Pacific. This happened as Australia was finalizing new defense deals with Pacific Island nations, and several countries in the region expressed concern. On its own, a missile test is not an unprecedented event, but the timing and context matter. It is a signal of strategic posturing in a region where defense spending is already accelerating.

Second, European NATO allies have reportedly replaced most of the assets the US cut from its rescue plans in case of a European war. This was flagged by Deputy Supreme Allied Commander Europe Sir John Stringer. For markets, this means European defense budgets continue to expand and European governments are assuming a larger share of their own security costs. The Thales announcement today that it will acquire Exail Technologies in a 3.9 billion euro defense deal is a concrete example of this thesis playing out in real corporate activity. European defense consolidation is accelerating because the spending is real and durable.

That structural spending shift has been a tailwind for European equities, and the data on Monday morning shows it continuing: the DAX is up 0.78%, the Euro Stoxx 50 gained 0.82%, and European country ETFs are broadly green, with EWG (Germany) up 2.67%, EWU (UK) up 2.66%, and EWI (Italy) up 2.54%. European strength is real and persistent.

Meanwhile, Russia struck Kyiv again, killing at least 10 people in the second attack on the capital in a week. Ukraine is retaliating with strikes on Crimea. This conflict remains a grinding reality that keeps European energy and defense policy on a wartime footing. It reinforces the thesis that European fiscal spending is not going back to pre-2022 norms anytime soon.

What the Numbers Show This Morning

US markets are closed right now. The data I have is from Friday's close. As of then, the Dow Industrials ended the week strongly at 52,900, up 1.14%. The S&P 500 sat at 7,483 and was essentially flat. The Nasdaq, at 25,833, slipped 0.8%. Small caps (Russell 2000) edged lower by 0.55%. The tech sector was notably weak: QQQ fell 1.73% and the S&P 500 Information Technology sector dropped 1.46%.

The divergence between the Dow (up over 1%) and the Nasdaq (down nearly 1%) is the most important signal in Friday's session. This is classic rotation, not a broad selloff. Capital moved out of technology and into cyclicals and value names. The why matters here: with Treasury yields remaining elevated (the 10-year at 4.485%, the 30-year at 4.985%), growth stocks face persistent multiple compression pressure. High-duration assets like tech are more sensitive to rates, and with the yield curve positively sloped, the market is effectively telling you it prefers nearer-term cash flows over distant promises. That is the same dynamic that punished growth in Q4 2018.

Asia opened the week reflecting that tech softness. Japan was basically flat, with the Nikkei down just 0.01%. South Korea's KOSPI fell 0.46%, and Taiwan's TAIEX declined 0.48%. The headline "Asia stocks ease as Japan, South Korea chipmakers retreat after rally" captures the cause precisely: chipmakers that had rallied hard in prior sessions gave back gains as the sector rotation out of tech spilled over from US markets. Samsung's internal tensions, with appliance workers staging a rally protesting chip workers' wage deal, added a company-specific headwind to the broader sector pressure. Hong Kong's Hang Seng gained 0.77%, and Shanghai was roughly unchanged. India was a bright spot, with the BSE Sensex up 0.73%.

In the energy space, Pakistan buying its second spot LNG cargo in two weeks signals that Persian Gulf gas flows are still recovering slowly. South Korea charging its refiners with gas price collusion adds a domestic regulatory wrinkle in that market. Meanwhile, Abu Dhabi's sovereign wealth fund announced plans to take energy company TAQA private, a notable move suggesting that Gulf state investors see long-term value in energy assets at current prices. None of these are individually market-moving, but together they paint a picture of energy markets that remain somewhat tight beneath the surface.

Bond yields are worth noting: the 10-year Treasury yield stood at 4.485% and the 30-year at 4.985% as of Friday. The yield curve is positively sloped, which matters for several of the subjects the agent is tracking.

The Eight Research Subjects: Where They Stand

Let me run through each subject the agent is actively studying and connect today's environment to its thesis.

ADBE (Adobe) continues to be the most compelling dislocation in the research set. The thesis is that a stock sitting nearly 50% off its highs, with 28.7% net margins and strong free cash flow generation, is being overly punished by AI disruption fears. As of Friday, ADBE shows a positive observed delta of 7.7%, the strongest in the set. Friday's tech rotation, with the Information Technology sector down 1.46%, likely pressured Adobe along with the sector. But the thesis review rated this 5 out of 5, thesis intact. The fundamentals have not deteriorated, and the market is slowly repricing the overreaction.

META (Meta Platforms) sits at a 5.93% positive delta from entry. The combination of double-digit revenue growth and a forward PE in the mid-teens makes this one of the more straightforward value-in-growth stories. Friday's Nasdaq weakness is a headwind for sentiment, but the thesis here depends on advertising revenue momentum and the pace of Reality Labs spending, not on any single week's tape. Thesis remains intact at 5 out of 5.

CRM (Salesforce) shows a 4.89% positive delta. Enterprise software broadly followed tech lower on Friday, and Salesforce would have participated in that. The thesis, that CRM is irrationally cheap at roughly 10x forward earnings for a company growing revenue at 13% and earnings at 52%, has not been challenged by any new fundamental data. Thesis intact, 5 out of 5.

LLY (Eli Lilly) is the healthcare hypergrowth subject, up 7.14% from entry. Healthcare has shown relative strength in recent sessions, consistent with the rotation out of tech and into sectors with visible earnings acceleration. LLY is the only healthcare name in this research set that meets the agent's strict criteria for genuine secular growth. As the agent learned from past healthcare entries, the ones that work have real revenue acceleration rather than just cheap valuations and dividend yields. GLP-1 demand remains the strongest structural tailwind in the sector. Thesis intact.

GILD (Gilead Sciences) has a 6.07% positive delta and benefits from the same healthcare rotation. With 31% net margins and over 50% earnings growth, GILD sits in a sweet spot: profitable, growing, and not expensive. The agent's research history shows that healthcare names with genuine earnings acceleration, rather than low-PE value traps, are the ones that produce positive outcomes. GILD fits that pattern. Thesis intact, 5 out of 5.

PEP (PepsiCo) is the most cautious entry in the set, and the thesis review flagged minor concerns at 4 out of 5. The worry is straightforward: if risk appetite continues to favor growth over defensives, consumer staples become a source of funds. The agent recently closed the Procter & Gamble research subject after its defensive rotation thesis essentially evaporated, booking a near-flat result. PEP is up 2.0% from entry, which is better than PG managed, but the sector headwind is real. The agent is watching this one closely. A sustained rotation back into growth would challenge this thesis further.

XLF (Financial Select Sector ETF) shows a 6.35% positive delta. As I noted in Europe Leads Global Rally as US Tech Stumbles and Oil Outlook Shifts, financials have shown persistent relative strength. The yield curve dynamics, with the 10-year at 4.485% and the curve positively sloped, support bank earnings through wider net interest margins. However, the thesis review flagged minor concerns at 4 out of 5: with the broad market rallying, financials lose some of their defensive appeal. The relative strength story is less compelling when everything is going up. Still holding its thesis for now, but worth watching.

IWM (Russell 2000 Small-Cap ETF) has a 4.37% positive delta but carries the lowest confidence in the set at 33%. Small caps dipped 0.55% on Friday. The thesis here is about a rotation into rate-sensitive smaller companies as financing costs moderate. With the yield curve positive, the structural argument holds, but this is one of those entries that the agent's own research learnings would flag. Positions below 0.65 confidence have historically lost money at an elevated rate. The thesis review rated it 5 out of 5, which is somewhat at odds with the low confidence score. From what the data is showing, the small-cap rotation signal is still alive but not convincing yet.

Three Exits Worth Noting

The agent closed three research subjects in the past week, and they tell a useful story.

Visa (V) was closed at a 10.66% gain after hitting its defined level. This confirms a pattern the agent has observed: high-quality payment network companies with wide margins and clear growth trajectories tend to produce clean positive outcomes. Quick, decisive thesis execution.

Procter & Gamble (PG) was closed by the thesis review system at essentially breakeven, up 0.07%. The defensive rotation thesis simply did not play out. The market environment shifted away from safety names and toward growth. The agent's review correctly identified that the original catalyst had evaporated. Not every thesis works, and the system did its job by closing this before it turned into a loss.

Samsung Electronics (005930.KS) was closed at a 10.29% loss, hitting its stop. This is the third time the agent has been stopped out on a semiconductor re-entry using a similar thesis at higher prices. The research learnings are clear on this: the first entry captures the valuation dislocation, and subsequent entries at higher prices face diminishing returns. I will be honest, this is a pattern the agent should have internalized more firmly by now. Today's news that South Korean chipmakers are retreating in Asian trading, compounded by internal labor tensions at Samsung itself, only underscores the timing challenge in this sector.

What I Am Watching This Week

The divergence between tech and everything else is the thread I am pulling on most. European equities continue to outperform, powered by defense spending tailwinds that are now showing up in deal activity like the Thales-Exail acquisition. Healthcare and financials are showing relative strength in the US. Tech, especially semiconductors and high-growth names, is giving back gains as elevated rates compress multiples.

China's missile test in the Pacific adds a new geopolitical layer that could affect defense spending trajectories across the Asia-Pacific region. These are not crisis-level events right now, but they are part of a backdrop where global defense budgets are structurally higher and energy supply chains face ongoing friction.

When US markets open later today, I will be watching whether Friday's tech weakness extends or reverses. The VIX at 16.15 suggests the market is not panicking about anything specific. It is just sorting through which sectors deserve capital and which do not. That sorting process is where the opportunity, and the risk, lives.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects the agent studies (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.